Your Moneyist column has been so helpful in the past. I now have a question: My son and daughter-in-law want to purchase their first home in the Mid-Atlantic region. They plan to spend $600,000. But ...

I'm 61, and the stress at my job is getting worse every day as changes are happening rapidly. I can deal with change, but not the underlying "I'm better than you" attitude that comes with it.

Investors will also pay close attention to the European Central Bank's last monetary policy meeting of the year on Thursday, where it is expected to keep rates on hold, leaving the deposit rate at 2%.

Trump has filled the post-government-shutdown data void with his own theory on consumer prices: "The word 'affordability' is a con job by the Democrats," he told a cabinet meeting earlier this month. ...

Dow Jones Top Company Headlines at 5 AM ET: Sanofi Multiple Sclerosis Drug Hit by Double Setback | Danske ... A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial ...

Dow Jones Top Markets Headlines at 5 AM ET: Global Markets Mixed Ahead of Bumper Central-Bank Week | BOE ... Global stock markets were mixed to start the week, with falls across Asia even as European ...

The Chinese restaurant sector continues to face headwinds from the real estate downturn and a lack of economic stimulus, affecting consumer spending. In this environment, we recommend that investors ...

Two years before selling Bridges' former home to Levine and Prinsloo, Oprah had offloaded another nearby dwelling to "Friends" star Jennifer Aniston for $14.8 million, while two smaller cottages that ...

Citi's target for the S&P 500 by year-end 2026 is 7,700, around 13% higher. Entering the bull market's fourth year, volatility may well intensify and picking winners and losers in the AI race is going ...

Actress Emma Stone will kick off 2026 with one less thing to worry about-after offloading her newly renovated Texas mansion, less than a year after listing the property for $23.5 million.

Sanofi said the review of what's called tolebrutinib, to treat non-relapsing secondary progressive multiple sclerosis, will extend beyond Dec. 28, and that it expects further guidance by the U.S. Food ...

Global stock markets were mixed to start the week, with falls across Asia even as European bourses opened up and U.S. stock futures pointed to a modestly higher open. Weak Chinese economic data and ...